Black Glove Holdings Targets Nigeria Amid Exclusive Deal to Deploy COVID Test Kits
Black Glove Holdings secured a strategic partnership with Natuurs Direct, a manufacturing company headquartered in the US. The technology received an Emergency Use Authorization (EUA) approval from the US Food and Drug Administration (FDA) earlier this year.
Natuurs Direct has appointed Dr. Pritesh Kumar to provide strategic advisory support to the operation in Nigeria. Having spent many years in the field consulting foreign governments and regulators, he brings a wealth of experience and contacts that will help move this business forward at a critical time.
"I am looking forward to providing scientific support to this partnership and help facilitate cutting-edge, cost-effective, and stable solutions to benefit Nigeria," said Dr. Kumar.
Black Glove Holdings is focused to aggressively open up the Nigerian market further and deploy these solutions quickly to the government. The company is targeting the states of Lagos, Niger, Ogun, Nassarawa, Oyo, Ekiti, and Osun, with an initial deployment in Lagos and Niger states.
The company also announced today it will be submitting the proprietary technology to The National Agency for Food, Drug Administration and Control (NAFDAC) for processing and will be seeking conditional emergency use approval for the multifunctional testing technology in Nigeria.
"Our scientists will facilitate and supervise the training and operation of COVID-19 testing facilities. We recognized the need for quality, rapid testing during this time and our proprietary protocols will support this goal," said Jörgen Van Dijk, Chief Corporate Officer.
Both Black Glove Holdings and NAD provide strategic advisory, operations, and subject matter expert services. Their team, collectively, has decades of experience in diagnostics, pharmaceuticals, manufacturing, and government. With their global connections, they have facilitated urgently needed items in short supply during the coronavirus pandemic.
Jörgen Van Dijk